News and Events

The 2022 American Glaucoma Society (AGS) Annual Meeting was held live at the Grand Hyatt Hotel in Nashville, TN March

Duke Ophthalmology is proud to report that resident Yuxi Zheng, MD and co-authors resident Xinxin (Steph) Zhang MD, Duke medical students Justin Ma, L

Duke Eye Center is proud to announce that several faculty members have been recognized as a 2022 Castle Connolly Top D

Duke glaucoma specialist Henry Tseng, MD, PhD discovered an important novel function for a gene called Optineurin through a collaboration with an interdisciplinary team of virologi

Sharon Freedman, MD, professor of ophthalmology and pediatric ophthalmology and strabismus division chief and her colleagues have had a productive year with continued clinical rese

Age-related macular degeneration (AMD) is the leading cause of vision loss in the elderly in the Western World.

Researchers at Duke Eye Center have identified that Netarsudil™ is particularly effective at treating steroid induced glaucoma. Results of the study were published in eLife in March 2021. 

Julie A. Woodward, MD, professor of ophthalmology and chief of the oculofacial and reconstructive surgery division continues to be a leader in the field.  

Sonja Beach visited Duke Eye Center for a consultation as a last resort in September 2020 after having almost unbearable pain and light sensitivity in her right eye after being treated for an eye i

She believed she could, so she did.